The Carlyle Group reports Q1 2026 earnings today after the close, with the Street broadly constructive but steadily paring back expectations ahead of the release.
The analyst setup tells the central story. Targets have moved almost uniformly lower over the past few weeks, yet no one has pulled their positive ratings. Goldman Sachs cut its target from $81 to $69 on April 7 while keeping a Buy. Morgan Stanley trimmed from $71 to $66 on April 21, maintaining Equal-Weight. JPMorgan moved from $67 to $66 on the day of the print. The lone dissenter in the recent period was Evercore ISI, which nudged its target up to $56 from $52. The mean target now stands at $61.81 against a $50.07 close — implying roughly 23% upside — but that gap partly reflects how quickly the stock has rebounded: CG gained nearly 8% over the past month and closed yesterday up 4.7%. The analyst direction of travel is cautious trimming, not conviction selling.
Short interest adds little heat to the setup. At 4.1% of the free float, it has actually eased — falling more than 5% over the past week and roughly 6% over the past month — suggesting short sellers were covering into the recent rally rather than pressing new positions. Borrow is cheap at 0.43% annualised, and availability remains ample, with no signs of squeeze pressure in the lending market. The options market tells a similarly muted story: the put/call ratio of 0.53 is marginally above its 20-day average of 0.47, a z-score of just 0.82 — closer to neutral than defensive. Neither options traders nor short sellers appear to be bracing for a sharp move.
The insider picture is worth noting, if only as context. Co-founders David Rubenstein and William Conway together hold more than 15% of the company. Rubenstein sold 500,000 shares in March at $46.68, a transaction worth $23.3 million. CEO Harvey Schwartz and several other senior executives — including both CFOs and the COO — sold stock on February 6 at around $55. Net insider selling over 90 days totals roughly $85.6 million. These trades predated the April pullback and partial recovery, and many likely reflect planned distributions rather than directional views, but the absence of buying from any named executive is a visible feature of the ownership backdrop.
The bull case rests on Carlyle's $474 billion in AUM and the durability of its global credit franchise at $208 billion. The bear case centres on deployment pace and whether carry realisation can keep up with AUM growth in a market environment that has challenged exits. Today's print is less a verdict on Carlyle's long-term positioning and more a test of whether fee-related earnings and deployment activity held up through a turbulent first quarter — and whether management's tone on the fundraising pipeline gives the Street reason to stop trimming.
See the live data behind this article on ORTEX.
Open CG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
